多多益善：癌症恶病质的多模态治疗方法。
More is better: a multimodality approach to cancer cachexia.
出版信息
Oncologist. 2010;15(2):119-21. doi: 10.1634/theoncologist.2010-0019. Epub 2010 Feb 4.
Abstract
The author comments on the findings of Mantovani et al. with combination therapy to treat cancer cachexia published in this issue of .
摘要
作者对曼托瓦尼等人在本期 杂志上发表的关于联合治疗癌症恶病质的研究结果进行了评论。
相似文献
1
More is better: a multimodality approach to cancer cachexia.多多益善：癌症恶病质的多模态治疗方法。
Oncologist. 2010;15(2):119-21. doi: 10.1634/theoncologist.2010-0019. Epub 2010 Feb 4.
2
The Evolving Approach to Management of Cancer Cachexia.癌症恶病质管理的不断演进方法
Oncology (Williston Park). 2017 Jan 15;31(1):23-32.
3
Cancer cachexia: Diagnosis, assessment, and treatment.癌症恶病质：诊断、评估与治疗。
Crit Rev Oncol Hematol. 2018 Jul;127:91-104. doi: 10.1016/j.critrevonc.2018.05.006. Epub 2018 May 31.
4
Cancer anorexia - cachexia syndrome.癌症厌食-恶病质综合征
Acta Med Indones. 2012 Apr;44(2):154-62.
5
Cancer cachexia: towards integrated therapeutic interventions.癌症恶病质：走向综合治疗干预
Expert Opin Biol Ther. 2014 Oct;14(10):1379-81. doi: 10.1517/14712598.2014.939068. Epub 2014 Jul 12.
6
Fatigue and cachexia in cancer patients.癌症患者的疲劳与恶病质
Support Care Cancer. 1998 Mar;6(2):77-8. doi: 10.1007/s005200050137.
7
Management of cancer cachexia.
Semin Oncol. 1985 Dec;12(4):452-60.
8
Cancer cachexia.癌症恶病质
Int J Cardiol. 2002 Sep;85(1):73-81. doi: 10.1016/s0167-5273(02)00235-8.
9
Cancer cachexia.癌症恶病质
Mol Cancer. 2003 Nov 5;2:36. doi: 10.1186/1476-4598-2-36.
10
Terminology in cancer cachexia: importance and status.癌症恶病质的术语：重要性和现状。
Curr Opin Clin Nutr Metab Care. 2012 May;15(3):220-5. doi: 10.1097/MCO.0b013e328352a895.
引用本文的文献
1
Cancer cachexia reduces the efficacy of immune checkpoint inhibitors in cancer patients.癌症恶病质降低了癌症患者免疫检查点抑制剂的疗效。
Aging (Albany NY). 2024 Mar 11;16(6):5354-5369. doi: 10.18632/aging.205652.
2
Cancer Cachexia and Dysregulated Phosphate Metabolism: Insights from Mutant p53 and Mutant Klotho Mouse Models.癌症恶病质与磷酸盐代谢失调：来自突变型p53和突变型klotho小鼠模型的见解
Metabolites. 2022 Dec 17;12(12):1284. doi: 10.3390/metabo12121284.
3
Cancer cachexia: Pathophysiology and association with cancer-related pain.癌症恶病质：病理生理学及其与癌痛的关联
Front Pain Res (Lausanne). 2022 Aug 22;3:971295. doi: 10.3389/fpain.2022.971295. eCollection 2022.
4
Cancer cachexia, recent advances, and future directions.癌症恶病质、最新进展及未来方向。
Cancer J. 2015 Mar-Apr;21(2):117-22. doi: 10.1097/PPO.0000000000000100.
5
Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome.正在研发用于治疗癌症相关厌食和恶病质综合征患者的药物。
Drug Des Devel Ther. 2013 Aug 12;7:645-56. doi: 10.2147/DDDT.S39771. eCollection 2013.
6
Understanding cancer-induced cachexia: imaging the flame and its fuel.了解癌症恶病质：成像火焰及其燃料。
Curr Opin Support Palliat Care. 2011 Dec;5(4):327-33. doi: 10.1097/SPC.0b013e32834c49ba.
本文引用的文献
1
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.332 例癌症恶病质患者 5 种不同治疗组的随机 III 期临床试验。
Oncologist. 2010;15(2):200-11. doi: 10.1634/theoncologist.2009-0153. Epub 2010 Feb 15.
2
Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer.超重或肥胖患者的肌肉减少症是胰腺癌的一个不利预后因素。
Clin Cancer Res. 2009 Nov 15;15(22):6973-9. doi: 10.1158/1078-0432.CCR-09-1525. Epub 2009 Nov 3.
3
Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.肌肉减少症作为接受卡培他滨治疗的转移性乳腺癌患者化疗毒性和肿瘤进展时间的一个决定因素。
Clin Cancer Res. 2009 Apr 15;15(8):2920-6. doi: 10.1158/1078-0432.CCR-08-2242. Epub 2009 Apr 7.
4
Components of the anorexia-cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia.厌食恶病质综合征的组成部分：癌症相关性厌食的胃肠道症状相关性。
Support Care Cancer. 2009 Dec;17(12):1531-41. doi: 10.1007/s00520-009-0623-5. Epub 2009 Apr 7.
5
Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group.定义和分类癌症恶病质：SCRINIO工作组的一项提议。
JPEN J Parenter Enteral Nutr. 2009 Jul-Aug;33(4):361-7. doi: 10.1177/0148607108325076. Epub 2008 Dec 24.
6
Cachexia: a new definition.恶病质：一个新定义。
Clin Nutr. 2008 Dec;27(6):793-9. doi: 10.1016/j.clnu.2008.06.013. Epub 2008 Aug 21.
7
A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.癌症相关疲劳药物治疗的系统评价与荟萃分析
J Natl Cancer Inst. 2008 Aug 20;100(16):1155-66. doi: 10.1093/jnci/djn250. Epub 2008 Aug 11.
8
A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia.英夫利昔单抗联合吉西他滨治疗胰腺癌恶病质的多中心II期研究。
J Support Oncol. 2008 Jan;6(1):18-25.
9
Biomarkers for cancer cachexia: is there also a genetic component to cachexia?癌症恶病质的生物标志物：恶病质是否也存在遗传因素？
Support Care Cancer. 2008 Mar;16(3):229-34. doi: 10.1007/s00520-007-0367-z. Epub 2007 Dec 11.
10
A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.依那西普治疗癌症厌食/体重减轻综合征的安慰剂对照双盲试验：来自中北部癌症治疗组N00C1的结果
Cancer. 2007 Sep 15;110(6):1396-403. doi: 10.1002/cncr.22944.
Zotero 插件